Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Amicus Therapeutics Inc (FOLD)

  • SEC News
  • Jan. 07, 2026, 00:47 UTC
  • 5
  • 1 comments

Castelli Jeff 🔴 sold 30.0K shares of AMICUS THERAPEUTICS, INC. (FOLD) at $14.27 Transaction Date: Jan 02, 2026 | Filing ID: 005047

Comment Full text

Amicus Therapeutics Inc (FOLD)

  • SEC News
  • Jan. 07, 2026, 00:46 UTC
  • 5
  • 1 comments

Prout Samantha 🔴 sold 15.7K shares of AMICUS THERAPEUTICS, INC. (FOLD) at $14.27 Transaction Date: Jan 02, 2026 | Filing ID: 005045

Comment Full text

Amicus Therapeutics Inc (FOLD)

  • SEC News
  • Jan. 07, 2026, 00:45 UTC
  • 4
  • 1 comments

Clark David Michael 🔴 sold 23.9K shares of AMICUS THERAPEUTICS, INC. (FOLD) at $14.27 Transaction Date: Jan 02, 2026 | Filing ID: 005043

Comment Full text

Protagonist Therapeutics Inc (PTGX)

  • SEC News
  • Jan. 07, 2026, 00:44 UTC
  • 4
  • 1 comments

Director SELICK HAROLD E 🟢 acquired 6.5K shares (1 derivative) of Protagonist Therapeutics, Inc (PTGX) at $87.18 Transaction Date: Jan 02, 2026 | Filing ID: 001479

Comment Full text

Anixa Biosciences Inc. (ANIX)

  • SEC News
  • Jan. 07, 2026, 00:44 UTC
  • 5
  • 1 comments

Director Titterton Lewis H jr 🟢 acquired 25.0K shares (1 derivative) of Anixa Biosciences Inc (ANIX) at $3.18 Transaction Date: Jan 05, 2026 | Filing ID: 000689

Comment Full text

Protagonist Therapeutics Inc (PTGX)

  • SEC News
  • Jan. 07, 2026, 00:42 UTC
  • 4
  • 1 comments

Director Waddill William D. 🟢 acquired 6.5K shares (1 derivative) of Protagonist Therapeutics, Inc (PTGX) at $87.18 Transaction Date: Jan 02, 2026 | Filing ID: 001478

Comment Full text

Anixa Biosciences Inc. (ANIX)

  • SEC News
  • Jan. 07, 2026, 00:42 UTC
  • 4
  • 1 comments

Director KUMAR AMIT 🟢 acquired 350.0K shares (1 derivative) of Anixa Biosciences Inc (ANIX) at $3.18 ($1.1M) Transaction Date: Jan 05, 2026 | Filing ID: 000688

Comment Full text

Anixa Biosciences Inc. (ANIX)

  • SEC News
  • Jan. 07, 2026, 00:41 UTC
  • 2
  • 1 comments

Director Gottschalk Emily 🟢 acquired 25.0K shares (1 derivative) of Anixa Biosciences Inc (ANIX) at $3.18 Transaction Date: Jan 05, 2026 | Filing ID: 000687

Comment Full text

Protagonist Therapeutics Inc (PTGX)

  • SEC News
  • Jan. 07, 2026, 00:41 UTC
  • 2
  • 1 comments

Director Giraudo Bryan 🟢 acquired 6.5K shares (1 derivative) of Protagonist Therapeutics, Inc (PTGX) at $87.18 Transaction Date: Jan 02, 2026 | Filing ID: 001477

Comment Full text

Anixa Biosciences Inc. (ANIX)

  • SEC News
  • Jan. 07, 2026, 00:41 UTC
  • 2
  • 1 comments

Catelani Michael 🟢 acquired 175.0K shares (1 derivative) of Anixa Biosciences Inc (ANIX) at $3.18 Transaction Date: Jan 05, 2026 | Filing ID: 000686

Comment Full text

Protagonist Therapeutics Inc (PTGX)

  • SEC News
  • Jan. 07, 2026, 00:40 UTC
  • 2
  • 1 comments

Director Williams Lewis T 🟢 acquired 6.5K shares (1 derivative) of Protagonist Therapeutics, Inc (PTGX) at $87.18 Transaction Date: Jan 02, 2026 | Filing ID: 001476

Comment Full text

Protagonist Therapeutics Inc (PTGX)

  • SEC News
  • Jan. 07, 2026, 00:39 UTC
  • 2
  • 1 comments

Director O'Dowd Sarah A 🟢 acquired 6.5K shares (1 derivative) of Protagonist Therapeutics, Inc (PTGX) at $87.18 Transaction Date: Jan 02, 2026 | Filing ID: 001475

Comment Full text

Protagonist Therapeutics Inc (PTGX)

  • SEC News
  • Jan. 07, 2026, 00:38 UTC
  • 2
  • 1 comments

Director PATEL DINESH V PH D 🟢 acquired 215.6K shares (1 derivative) of Protagonist Therapeutics, Inc (PTGX) at $87.18 ($10.5M) Transaction Date: Jan 02, 2026 | Filing ID: 001474

Comment Full text

Protagonist Therapeutics Inc (PTGX)

  • SEC News
  • Jan. 07, 2026, 00:37 UTC
  • 4
  • 1 comments

Ali Asif 🟢 acquired 57.6K shares (1 derivative) of Protagonist Therapeutics, Inc (PTGX) at $87.18 ($2.8M) Transaction Date: Jan 02, 2026 | Filing ID: 001472

Comment Full text

Protagonist Therapeutics Inc (PTGX)

  • SEC News
  • Jan. 07, 2026, 00:35 UTC
  • 2
  • 1 comments

MOLINA ARTURO MD 🟢 acquired 57.6K shares (1 derivative) of Protagonist Therapeutics, Inc (PTGX) at $87.18 ($2.8M) Transaction Date: Jan 02, 2026 | Filing ID: 001471

Comment Full text
  • Previous
  • 563
  • 564
  • 565
  • 566
  • 567
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191985)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125295)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin